BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Aug 4, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-08-02

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-02	Common Stock	M	18687	$6.13	Acquired	101847	Direct
2011-08-02	Common Stock	S	18687	$30.55	Acquired	83160	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-02	Common Stock	$6.13	M	18687	Disposed	2015-01-06	Common Stock (18687)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $30.23 to $30.75. the reporting person will provide to the issuer, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vested 6/48ths on June 7, 2006 and 1/48th on the 7th of every month thereafter.